LBA59Primary efficacy and updated safety of ceritinib (450 mg or 600 mg) with food vs 750 mg fasted in ALK+ metastatic NSCLC (ASCEND-8)Byoung Chul Cho,Radka Obermannová,Sergey Orlov,U Batra,Sarayut Lucien Geater,Mark J. McKeage,C.-K. Yang,P E Postmus,G. de Castro,S. Kim,P De Marchi, G B Kanakasetty, V. Sriuranpong, P J Voon,Y. Lau, F Kiertsman,V Q Passos,Z Chen,Rafal DziadziuszkoANNALS OF ONCOLOGY（2018）引用 3|浏览55暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
